Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 285

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

Open access
Friedrich, Mirco J., Neri, Paola, Kehl, Niklas, Michel, Julius, Steiger, Simon, Kilian, Michael, Leblay, Noémie, Maity, Ranjan, Sankowski, Roman, Lee, Holly, Barakat, Elie, Ahn, Sungwoo, Weinhold, Niels, Rippe, Karsten, Bunse, Lukas, Platten, Michael, Goldschmidt, Hartmut, Müller-Tidow, Carsten, Raab, Marc-Steffen, Bahlis, Nizar J. · 2023 · Cancer Cell

Abstract

Bispecific T cell engagers (TCEs) have shown promise in the treatment of various cancers, but the immunological mechanism and molecular determinants of primary and acquired resistance to TCEs remain poorly understood. Here, we identify conserved behaviors of bone marrow-residing T cells in multiple myeloma patients undergoing BCMAxCD3 TCE therapy. We show that the immune repertoire reacts to TCE therapy with cell state-dependent clonal expansion and find evidence supporting the coupling of tumor recognition via major histocompatibility complex class I (MHC class I), exhaustion, and clinical response. We find the abundance of exhausted-like CD8 + T cell clones to be associated with clinical response failure, and we describe loss of target epitope and MHC class I as tumor-intrinsic adaptations to TCEs. These findings advance our understanding of the in vivo mechanism of TCE treatment in humans and provide the rationale for predictive immune-monitoring and conditioning of the immune repertoire to guide future immunotherapy in hematological malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2023.02.008

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 285

Metadata

Authors
Friedrich, M. J., Neri, P., Kehl, N., Michel, J., Steiger, S., Kilian, M., Leblay, N., Maity, R., Sankowski, R., Lee, H., Barakat, E., Ahn, S., Weinhold, N., Rippe, K., Bunse, L., Platten, M., Goldschmidt, H., Müller-Tidow, C., Raab, M.-S., & Bahlis, N. J.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2023-04
Volume
41
Issue
4
Pages
711-725.e6
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4323656441
Cited by
285
References
54
FWCI
50.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. https://app.cochat.ai/papers/10.1016/j.ccell.2023.02.008
The paper
Friedrich, M. J., Neri, P., Kehl, N., Michel, J., Steiger, S., Kilian, M., Leblay, N., Maity, R., Sankowski, R., Lee, H., Barakat, E., Ahn, S., Weinhold, N., Rippe, K., Bunse, L., Platten, M., Goldschmidt, H., Müller-Tidow, C., Raab, M.-S., & Bahlis, N. J. (2023). The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. https://doi.org/10.1016/j.ccell.2023.02.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.